Investor Relations
Annual Report 2023
Annual Reports
Investor enquiries
Main Contacts
Andy Barnett
Head of Investor Relations
Isabel Gibson
肿瘤学
Christer Gruvris
BioPharmaceuticals
(Cardiovascular, Renal and Metabolism),
金融 & Fixed Income
Rachel Korolyshun
Rare Disease,
Environment, Social and 治理
Morgan Sanford
肿瘤学
Philip Sparks
BioPharmaceuticals
(呼吸 & 免疫学, Vaccines & Immune Therapies)
Lauren Swales
Rare Disease,
Environment, Social and 治理
-
Shareholder information
Please find relevant shareholder information and shareholder tools on this page
-
Shareholder 常见问题
Answers to frequently asked shareholder questions
-
治理
We apply the principles of good corporate governance in the UK Corporate 治理 Code and related guidance
